相关实验视频
Updated: Jun 20, 2026

07:34
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
9.6K
高血纤维细胞生长因子19与急性缺血性中风患者的预后改善有关
Xiao Ren1, Pinni Yang2, Lulu Sun2
1Public Health Research Center and Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, China.
Clinical nutrition (Edinburgh, Scotland)
|March 21, 2025
概括
较高的血纤维细胞生长因子19 (FGF-19) 水平与急性缺血性中风患者的更好的结果相关. 这表明FGF-19可能作为一个有价值的生物标志物来预测中风后的良好预后.
科学领域:
- 生物化学和分子生物学
- 神经学 神经学
- 心血管研究研究心血管研究
背景情况:
- 急性缺血性中风是全球死亡和残疾的主要原因.
- 确定可靠的预后生物标志物对于患者管理至关重要.
- 纤维细胞生长因子19 (FGF-19) 已成为各种生理过程中的潜在因素.
研究的目的:
- 为了前性地研究血FGF-19水平和诊断为急性缺血性中风的患者的临床结果之间的关联.
- 确定FGF-19是否可以作为中风预后的预测生物标志物.
主要方法:
- 血FGF-19水平在3048名缺血性中风患者的基线测量.
- 患者被跟踪了一年,以评估主要结果 (死亡或严重残疾) 和次要结果.
- 采用多变量分析来调整混因素.
主要成果:
- 高血FGF-19水平与中风后一年死亡或严重残疾风险降低显著相关.
- 每次FGF-19标准偏差的增加都与初级结局风险降低20%有关.
- 在与传统风险因素相结合时,FGF-19的添加改善了缺血性中风患者的预测结果.
结论:
- 血FGF-19水平升高表明急性缺血性中风患者的预后有所改善.
- 在缺血性中风患者中,FGF-19显示出作为一个有前途的生物标志物,具有良好的预后的潜力.
- 结合高FGF-19和低FGF-21水平与最低的不良结果发生率有关.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

